Published in Clin Exp Immunol on July 01, 1969
Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. J Clin Invest (1975) 1.86
Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis. J Clin Invest (1975) 1.62
Inhibitory effect of rheumatoid sera on cell damage by lymphocytes. Ann Rheum Dis (1972) 1.40
Studies into the occurrence of soluble antigen-antibody complexes in disease. VI. Further characterization of the biological and physical properties of the rheumatoid biologically active factor (RBAF). Clin Exp Immunol (1974) 0.75
1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis (1958) 24.41
The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med (1956) 19.55
QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol (1965) 16.97
Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med (1961) 10.94
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Pathogenesis of serum sickness. AMA Arch Pathol (1958) 6.47
Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med (1968) 5.95
Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest (1961) 5.62
Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64
Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest (1967) 4.31
The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med (1968) 4.29
Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels. J Exp Med (1968) 3.80
The pathogenesis of glomerulonephritis. Am J Med (1968) 3.61
THE ROLE OF ANTIGEN-ANTIBODY COMPLEXES IN DISEASE. Harvey Lect (1963) 2.20
Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes. Clin Exp Immunol (1968) 1.47
Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases. Clin Exp Immunol (1968) 1.45
Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers. Clin Exp Immunol (1968) 1.15
Systemic lupus erythematosus and L. E. cell phenomenon. Postgrad Med (1954) 0.88
Symposium: recent trends in limb fitting. Control methods for powered prostheses. Proc R Soc Med (1966) 0.81
Fibromyalgia--out of control? J Rheumatol (1997) 4.29
Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59
The bimodal mortality pattern of systemic lupus erythematosus. Am J Med (1976) 3.47
Perennial Antarctic lake ice: an oasis for life in a polar desert. Science (1998) 3.20
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med (1973) 2.98
Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis (1998) 2.65
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced conventional spin-echo MR? AJNR Am J Neuroradiol (1996) 2.24
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res (1999) 2.21
Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet (1989) 2.20
XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis (2000) 2.16
Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med (1977) 2.09
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A (1993) 1.93
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res (1997) 1.92
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res (1993) 1.89
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81
Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol (1983) 1.80
Videotape educational program for people with asthma. Can Med Assoc J (1979) 1.76
Comparison of respiratory variables in grain elevator workers and civic outside workers of Thunder Bay, Canada. Am Rev Respir Dis (1979) 1.71
Asthmatic subjects symptomatically worse at work: prevalence and characterization among a general asthma clinic population. Chest (2000) 1.67
Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. IV. Natural history. J Allergy Clin Immunol (1974) 1.66
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst (1998) 1.64
Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum (1980) 1.62
Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res (2001) 1.61
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (1998) 1.58
Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.57
A workers' compensation claim population for occupational asthma. Comparison of subgroups. Chest (1995) 1.55
Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer (1999) 1.55
The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol (1991) 1.52
Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem (1993) 1.50
The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol (1998) 1.50
Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol (2000) 1.48
Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. 3. Second survey of the community. J Allergy Clin Immunol (1974) 1.48
Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes. Clin Exp Immunol (1968) 1.47
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases. Clin Exp Immunol (1968) 1.45
Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol (1997) 1.44
Prognostic significance of DNA content in epithelial ovarian cancer. Gynecol Oncol (1994) 1.43
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.43
Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia. Gynecol Oncol (1993) 1.42
A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum (1988) 1.40
Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin. J Clin Invest (1984) 1.40
GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.40
The influence of humidity, sunlight, and temperature on the daytime decay of polyaromatic hydrocarbons on atmospheric soot particles. Environ Sci Technol (1988) 1.39
Musculoskeletal disability and rheumatology. J Rheumatol (1994) 1.38
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol (2000) 1.35
Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.35
Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma. Am J Med (1973) 1.35
Thrombosis of the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol (1995) 1.32
Grain elevator workers show work-related pulmonary function changes and dose-effect relationships with dust exposure. Br J Ind Med (1982) 1.29
Synovial fluid examination for the diagnosis of amyloidosis. Ann Rheum Dis (1973) 1.29
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med (1985) 1.28
Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells. J Immunol (1986) 1.28
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (1996) 1.28
The cauda equina syndrome of ankylosing spondylitis. Ann Intern Med (1973) 1.27
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG. J Exp Med (1971) 1.27
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog (1996) 1.27
Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion. Eur J Immunol (1978) 1.26
Synthesis, assembly and secretion of gamma-globulin by mouse myeloma cells. V. Balanced and unbalanced synthesis of heavy and light chains by IgG-producing tumors and cell lines. J Immunol (1973) 1.26
Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis (2000) 1.25
Irritant-induced occupational asthma. Chest (1989) 1.24
Immunoglobulin production and secretion by variant clones of the MOPC 315 mouse myeloma cell line. J Immunol (1980) 1.23
Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods. Cancer (1983) 1.23
Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res (1996) 1.23
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc Natl Acad Sci U S A (1996) 1.22
Production of human normal adult and fetal hemoglobins in Escherichia coli. Protein Eng (1997) 1.22
Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis (1996) 1.22
Azathioprine in rheumatoid arthritis: a long-term follow-up study. Arthritis Rheum (1975) 1.22
The NavChair Assistive Wheelchair Navigation System. IEEE Trans Rehabil Eng (1999) 1.21
Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ Health Perspect (1998) 1.20
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res (1998) 1.20
A systematic controlled study of pulmonary abnormalities in rheumatoid arthritis. J Rheumatol (1983) 1.19
Synthesis, assembly and secretion of mouse immunoglobulin. Transplant Rev (1973) 1.19
Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics (1994) 1.19
Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res (1995) 1.19
Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum (1986) 1.18
Salivary gland components involved in the formation of squamous metaplasia. Am J Pathol (1985) 1.18
Malignant myoepithelioma of the breast. An immunohistochemical study by light and electron microscopy. Cancer (1986) 1.18
Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther (2001) 1.18
Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of human autoimmune responses. J Immunol (1989) 1.17
Changes in Ia expression in mouse kidney during acute graft-vs-host disease. J Immunol (1984) 1.17
Outer medullary circulatory defect in ischemic acute renal failure. Am J Pathol (1984) 1.16
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene (1996) 1.16
Effect of layoff and rehire on respiratory variables of grain elevator workers. Am Rev Respir Dis (1980) 1.16
Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes. Methods Enzymol (1986) 1.15
Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney. Pediatrics (1984) 1.15
Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers. Clin Exp Immunol (1968) 1.15
Genetic variability in susceptibility and response to toxicants. Toxicol Lett (2001) 1.15
Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med (1997) 1.13
Azathioprine in rheumatoid arthritis. A double-blind, cross over study. Arthritis Rheum (1973) 1.12
Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability. J Immunol (1975) 1.11